Your session is about to expire
← Back to Search
Behavioral Intervention
Mindful Walking for Parkinson's Disease (MM-RCT Trial)
N/A
Waitlist Available
Led By Gammon Earhart, PhD
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 14 weeks
Awards & highlights
MM-RCT Trial Summary
This trial will test if mindfulness-based walking can help people with PD and FOG reduce their symptoms and improve their quality of life.
Who is the study for?
This trial is for people over 55 with Parkinson's disease who experience freezing of gait (FOG), a condition that hinders normal stepping. Participants must be diagnosed by a neurologist, have a history of FOG, and can walk independently for at least five minutes. They should not have dementia, be planning deep brain surgery soon, or have other medical issues that would limit safe participation.Check my eligibility
What is being tested?
The study compares Mindfulness Based Walking Therapy (MBWT) to an educational program about FOG in individuals with Parkinson's. MBWT aims to reduce stress and improve mobility by increasing awareness and self-compassion. The effectiveness will be measured through this randomized controlled trial.See study design
What are the potential side effects?
Since the interventions involve mindfulness practices and education without medications or invasive procedures, significant side effects are not expected. However, participants may experience emotional discomfort when discussing their experiences with FOG.
MM-RCT Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 14 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~14 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Adherence: Number of Hours Participants Practice Mindfulness at Home
Attendance of Participants: Number of Participants at Each Session
Recruitment of Sample: Number of Participants Recruited
+1 moreMM-RCT Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Mindfulness-Based Walking Therapy (MBWT)Experimental Treatment1 Intervention
Participants will receive the MBWT intervention.
Group II: Freezing of Gait (FOG) EducationPlacebo Group1 Intervention
Participants will receive educational materials about FOG and track their usual care.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Mindfulness Based Walking Therapy (MBWT)
2022
N/A
~10
Find a Location
Who is running the clinical trial?
Washington University School of MedicineLead Sponsor
1,937 Previous Clinical Trials
2,299,671 Total Patients Enrolled
Gammon Earhart, PhDPrincipal InvestigatorWashington University School of Medicine
Kerri Rawson, PhDPrincipal InvestigatorWashington University School of Medicine
1 Previous Clinical Trials
9 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My Parkinson's disease is between stages I and IV.I have been diagnosed with Parkinson's disease by a neurologist.I have a neurological condition that is not Parkinson's disease.I can walk by myself for at least five minutes, with or without help from a device.I am able to follow the study's requirements.I have a medical condition that makes it unsafe for me to participate in certain activities.I might have deep brain stimulation surgery in the next 6 months.I am 55 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Mindfulness-Based Walking Therapy (MBWT)
- Group 2: Freezing of Gait (FOG) Education
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this experiment currently open for enrollment?
"Indeed, the records hosted on clinicaltrials.gov show that this medical experiment is actively accepting applicants. The trial was initially posted in June 7th 2023 and modified as recently as June 27th of the same year. This study requires 30 test subjects from a single research centre."
Answered by AI
How many participants are able to take part in the clinical trial?
"Affirmative. Clinicaltrials.gov information corroborates that this clinical trial is still enrolling patients; it was posted on June 7th 2023 and the most recent update occurred on June 27th 2023, with a total of 30 participants being sought from one site."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger